Modular Medical, Inc. (MODD)
| Market Cap | 15.10M -59.7% |
| Revenue (ttm) | n/a |
| Net Income | -28.24M |
| EPS | -12.36 |
| Shares Out | 5.41M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 48,582 |
| Open | 2.600 |
| Previous Close | 2.640 |
| Day's Range | 2.570 - 2.800 |
| 52-Week Range | 2.570 - 30.000 |
| Beta | 0.07 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 13, 2026 |
About MODD
Modular Medical, Inc. operates as a medical device company. The company focuses on the design, development, and commercialization of insulin pumps. It also offers MODD1, a two-part patch pump for type-1 and type-2 diabetes. Modular Medical, Inc. is headquartered in San Diego, California.
Financial Performance
Financial StatementsNews
Modular Medical, IMO Health launch strategic pilot
Modular Medical (MODD) announced an important pilot collaboration with IMO Health. Through this pilot, Modular Medical and IMO Health expect to develop a deployable terminology-powered phenotypic algo...
Modular Medical and IMO Health Launch Strategic Pilot to Enable Real Time Insulin Pump Patient Identification Into Electronic Health Records
Pilot Combines Clinician Guided Phenotypes with IMO Health's Unique Terminology Identifiers to Help Clinicians Easily Identify Patients Most Likely to Benefit from Pivot Insulin Pump Therapy Advancing...
Modular Medical releases findings from independent study on Pivot pump
Modular Medical (MODD) released findings from an independent market research study demonstrating positive receptivity to its FDA-cleared Pivot tubeless patch pump due to its differentiated design, str...
Modular Medical Receives Research Demonstrating Positive Payor Reception of Pivot Tubeless Patch Pump
Completed Independent Study Strongly Supports Favorable Payor Receptivity to Pivot's Differentiated Design and Simplified User Experience, and provides further validation of significant progress towar...
Modular Medical reports findings from diabetes patient research initiative
Modular Medical (MODD) announced findings from a new comprehensive diabetes patient research initiative further supporting its commercialization strategy. The Company will share these findings and sho...
Modular Medical Announces Completion of Research Initiative Indicating Strong Interest in Simpler Insulin Delivery
97% of Surveyed Injection Users Would Consider Pump Therapy - if Easier to Learn and Improved Outcomes Conducting Additional Research Initiative in Conjunction with Commercialization of the Pivot Tube...
Modular Medical Announces FDA Submission of Pivot Tubeless Insulin Patch Pump Enhancements
Submission Covers Software Enhancements for Patient Flexibility and Customization of Pivot SAN DIEGO, CA / ACCESS Newswire / July 1, 2026 / Modular Medical, Inc. ("Modular Medical" or "the Company") (...
Modular Medical delivers insulin to first patients on Pivot pump
Modular Medical (MODD) announced that the first patients have completed onboarding and training and are now actively using the Pivot tubeless insulin patch pump in real-world settings. This milestone ...
Modular Medical Delivers Insulin to First Patients on Pivot Tubeless Insulin Patch Pump
First Patients Began Device Training and Insulin Delivery Today, Marking Transition to a Commercial Company Pivot is the First Insulin Pump Designed to Address the Large, Underserved Population of Ins...
Modular Medical announces shipment of Pivot tubeless patch pumps
Modular Medical (MODD) announced that the Pivot tubeless insulin patch pump is now shipping to physician offices for training. Upon completion of training, these pumps will be presented to potential…
Modular Medical Announces Shipment of Pivot Tubeless Patch Pumps
Pivot starter kits are now shipping to multiple endocrinology practices SAN DIEGO, CA / ACCESS Newswire / June 26, 2026 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a le...
Modular Medical announces commercial availability of Pivot
Modular Medical (MODD) announced that the Pivot, tubeless insulin patch pump, is now commercially available. This marks the start of real-world patient use, and the Company’s transition to a commercia...
Modular Medical Announces Commercial Availability of Pivot Tubeless Insulin Patch Pump Ahead of Commercial Expansion
The Pivot tubeless insulin patch pump is now commercially available in the U.S. following FDA 510(k) clearance in April Pivot represents a differentiated solution for insulin-dependent adults still on...
Modular Medical launches site for Pivot tubeless insulin patch pump
Modular Medical (MODD) announced the launch of PivotPump.com, a patient-focused website designed to support individuals seeking a simpler path to insulin pump therapy. This launch follows the Company’...
Modular Medical Launches New Website for Pivot Tubeless Insulin Patch Pump
Initial patients expected in June 2026 SAN DIEGO, CA / ACCESS Newswire / June 4, 2026 / Modular Medical, Inc. ("Modular Medical" or the "Company") (NASDAQ:MODD), a leader in innovative, patient-centri...
Modular Medical Inc trading halted, volatility trading pause
09:34 EDT Modular Medical (MODD) Inc trading halted, volatility trading pause
Modular Medical Inc trading resumes
09:39 EDT Modular Medical (MODD) Inc trading resumes
Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event Titled "From FDA Wins to Scaling Manufacturing - What Investors Should Watch." Featuring Modular Medical CEO - Friday, May 1, 2026
Meet with Modular Medical CEO Jeb Besser There are 4.8 million individuals with diabetes in the US that require daily insulin. Only 20% currently use an insulin pump.
Modular Medical files $150M mixed securities shelf
08:06 EDT Modular Medical (MODD) files $150M mixed securities shelf
Modular Medical Announces Pricing of $3.4 Million Registered Direct Offering of Common Stock
SAN DIEGO, CA / ACCESS Newswire / April 19, 2026 / Modular Medical, Inc. ("Modular Medical" or the "Company") (NASDAQ:MODD), a leader in innovative, patient-centric insulin delivery, today announced t...
Modular Medical regains compliance with Nasdaq minimum bid price rule
Modular Medical (MODD) received a letter from the Nasdaq Stock Market notifying the Company that it has regained compliance with the Nasdaq Capital Market’s minimum bid price continued listing require...
Modular Medical regains compliance with Nasdaq minimum bid price rule
Modular Medical (MODD) received a letter from the Nasdaq Stock Market notifying the Company that it has regained compliance with the Nasdaq Capital Market’s minimum bid price continued listing require...
Modular Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement
SAN DIEGO, CA / ACCESS Newswire / April 16, 2026 / Modular Medical, Inc. ("Modular Medical" or the "Company") (NASDAQ:MODD), a leader in innovative, patient-centric insulin delivery, today announced t...
Modular Medical receives FDA 510(k) clearance for Pivot insulin patch pump
Modular Medical (MODD) announced U.S. Food and Drug Administration 510(k) clearance for its next-generation Pivot tubeless insulin patch pump. This milestone clears the path for commercial availabilit...
Modular Medical Receives FDA 510(k) Clearance for Pivot Tubeless Insulin Patch Pump
First Removable 2-Part Design Targets $3 Billion "Almost-Pumper" Market with Expected Q2 2026 initial deployment. Key Milestones & Investment Highlights: FDA 510(k) Clearance Achieved: Pivot™ pump now...